SAM
CDNA icon

Silvercrest Asset Management’s CareDx CDNA Stock Holding History

Silvercrest Asset Management’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.44M Sell
296,200
-14,339
-5% -$312K 0.06% 380
2026
Q1 		$5.39M Sell
310,539
-60,870
-16% -$1.15M 0.04% 415
2025
Q4 		$7M Hold
371,409
– – 0.05% 387
2025
Q3 		$5.4M Sell
371,409
-10,528
-3% -$150K 0.04% 416
2025
Q2 		$7.46M Hold
381,937
– – 0.05% 367
2025
Q1 		$6.78M Buy
+381,937
New +$8.23M 0.05% 356
2023
Q1 		– Sell
-352,387
Closed -$4.02M – 800
2022
Q4 		$4.02M Sell
352,387
-150,067
-30% -$2.22M 0.03% 374
2022
Q3 		$8.55M Buy
502,454
+39,961
+9% +$858K 0.07% 240
2022
Q2 		$9.93M Sell
462,493
-15,205
-3% -$422K 0.08% 233
2022
Q1 		$17.7M Buy
477,698
+87,372
+22% +$3.41M 0.11% 198
2021
Q4 		$17.8M Buy
390,326
+173,205
+80% +$9.04M 0.11% 194
2021
Q3 		$13.8M Buy
217,121
+38,034
+21% +$2.9M 0.09% 221
2021
Q2 		$16.4M Sell
179,087
-412
-0.2% -$32.7K 0.11% 207
2021
Q1 		$12.2M Sell
179,499
-23,567
-12% -$1.83M 0.08% 242
2020
Q4 		$14.7M Sell
203,066
-71,054
-26% -$4.12M 0.11% 204
2020
Q3 		$10.4M Sell
274,120
-4,782
-2% -$161K 0.09% 225
2020
Q2 		$9.88M Sell
278,902
-4,950
-2% -$141K 0.09% 211
2020
Q1 		$6.2M Buy
283,852
+9,819
+4% +$220K 0.07% 244
2019
Q4 		$5.91M Sell
274,033
-11,724
-4% -$269K 0.05% 312
2019
Q3 		$6.46M Buy
+285,757
New +$7.91M 0.05% 282

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Silvercrest Asset Management's CDNA Position: Q2 2026 in Review

Silvercrest Asset Management reduced its CareDx (CDNA) stake by 4.6% in Q2 2026, selling an estimated $312K and leaving 296,200 shares worth $8.44M. The position accounts for 0.06% of the portfolio, ranked #380.

Silvercrest Asset Management first reported a position in CDNA in Q3 2019 and has held it in 20 quarters since. The position peaked at $17.8M in Q4 2021. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Silvercrest Asset Management held 296,200 shares of CareDx worth $8.44M as of Q2 2026.
  • Silvercrest Asset Management sold 14,339 CareDx shares in Q2 2026, an estimated $312K.
  • CareDx made up 0.06% of Silvercrest Asset Management's portfolio in Q2 2026, its #380 holding.
  • Silvercrest Asset Management first reported a position in CareDx in Q3 2019 and has held it in 20 quarters since.
  • Silvercrest Asset Management's CareDx position peaked at $17.8M in Q4 2021.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.